1. Home
  2. SLDB vs PLBC Comparison

SLDB vs PLBC Comparison

Compare SLDB & PLBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • PLBC
  • Stock Information
  • Founded
  • SLDB 2013
  • PLBC 1980
  • Country
  • SLDB United States
  • PLBC United States
  • Employees
  • SLDB N/A
  • PLBC N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • PLBC Finance Companies
  • Sector
  • SLDB Health Care
  • PLBC Finance
  • Exchange
  • SLDB Nasdaq
  • PLBC Nasdaq
  • Market Cap
  • SLDB 227.3M
  • PLBC 253.9M
  • IPO Year
  • SLDB 2018
  • PLBC 2005
  • Fundamental
  • Price
  • SLDB $4.03
  • PLBC $46.04
  • Analyst Decision
  • SLDB Strong Buy
  • PLBC Buy
  • Analyst Count
  • SLDB 11
  • PLBC 2
  • Target Price
  • SLDB $17.91
  • PLBC $52.50
  • AVG Volume (30 Days)
  • SLDB 279.8K
  • PLBC 8.4K
  • Earning Date
  • SLDB 11-06-2024
  • PLBC 01-15-2025
  • Dividend Yield
  • SLDB N/A
  • PLBC 2.20%
  • EPS Growth
  • SLDB N/A
  • PLBC N/A
  • EPS
  • SLDB N/A
  • PLBC 4.77
  • Revenue
  • SLDB N/A
  • PLBC $79,873,000.00
  • Revenue This Year
  • SLDB N/A
  • PLBC N/A
  • Revenue Next Year
  • SLDB N/A
  • PLBC $15.50
  • P/E Ratio
  • SLDB N/A
  • PLBC $10.27
  • Revenue Growth
  • SLDB N/A
  • PLBC 3.64
  • 52 Week Low
  • SLDB $4.00
  • PLBC $32.50
  • 52 Week High
  • SLDB $15.05
  • PLBC $51.33
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 29.01
  • PLBC 41.54
  • Support Level
  • SLDB $4.82
  • PLBC $47.68
  • Resistance Level
  • SLDB $5.40
  • PLBC $49.63
  • Average True Range (ATR)
  • SLDB 0.34
  • PLBC 1.10
  • MACD
  • SLDB -0.08
  • PLBC -0.45
  • Stochastic Oscillator
  • SLDB 1.63
  • PLBC 0.00

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About PLBC Plumas Bancorp

Plumas Bancorp is a bank holding company that provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.

Share on Social Networks: